AUTHOR=Tang Guo-Qing , Tang Yalan , Dhamnaskar Ketki , Hoarty Michelle D. , Vyasamneni Rohit , Vadysirisack Douangsone D. , Ma Zhong , Zhu Nanqun , Wang Jian-Guo , Bu Charlie , Cong Bestine , Palmer Elizabeth , Duda Petra W. , Sayegh Camil , Ricardo Alonso 

TITLE=Corrigendum: Zilucoplan, a macrocyclic peptide inhibitor of human complement component 5, uses a dual mode of action to prevent terminal complement pathway activation

JOURNAL=Frontiers in Immunology

VOLUME=14

YEAR=2023

URL=https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2023.1282155

DOI=10.3389/fimmu.2023.1282155

ISSN=1664-3224